Alyeska Investment Group L.P. Raises Stock Holdings in Docusign Inc. $DOCU

Key Points

• Alyeska Investment Group L.P. increased its stake in Docusign Inc. by 85.6%, owning approximately 764,056 shares valued at $62.19 million as of its latest SEC filing.
• Multiple analysts have lowered their price targets for Docusign, with ratings ranging from "Hold" to "Neutral," resulting in an average target price of $89.77.
• Docusign's board has authorized a stock repurchase program allowing the buyback of up to $1.00 billion in outstanding shares, indicating confidence in the company’s valuation.

Alyeska Investment Group L.P. increased its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 85.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 764,056 shares of the company's stock after purchasing an additional 352,451 shares during the period. Alyeska Investment Group L.P. owned approximately 0.38% of Docusign worth $62,194,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of DOCU. Ameriprise Financial Inc. increased its position in shares of Docusign by 24.7% in the fourth quarter. Ameriprise Financial Inc. now owns 1,186,106 shares of the company's stock worth $106,703,000 after purchasing an additional 235,145 shares during the last quarter. Captrust Financial Advisors grew its position in Docusign by 8.8% during the fourth quarter. Captrust Financial Advisors now owns 41,989 shares of the company's stock valued at $3,776,000 after acquiring an additional 3,402 shares during the last quarter. Cetera Investment Advisers grew its position in Docusign by 11.8% during the fourth quarter. Cetera Investment Advisers now owns 50,329 shares of the company's stock valued at $4,527,000 after acquiring an additional 5,302 shares during the last quarter. CoreCap Advisors LLC grew its position in Docusign by 113.4% during the fourth quarter. CoreCap Advisors LLC now owns 2,044 shares of the company's stock valued at $184,000 after acquiring an additional 1,086 shares during the last quarter. Finally, Deutsche Bank AG grew its position in Docusign by 26.3% during the fourth quarter. Deutsche Bank AG now owns 546,078 shares of the company's stock valued at $49,114,000 after acquiring an additional 113,608 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Docusign news, CFO Blake Jeffrey Grayson sold 15,143 shares of the company's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total value of $1,132,696.40. Following the transaction, the chief financial officer owned 110,723 shares of the company's stock, valued at $8,282,080.40. This represents a 12.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, June 16th. The stock was sold at an average price of $74.37, for a total value of $39,713.58. Following the transaction, the director directly owned 8,805 shares in the company, valued at $654,827.85. The trade was a 5.72% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 78,552 shares of company stock worth $5,983,631. Insiders own 1.66% of the company's stock.

Docusign Price Performance

Shares of NASDAQ DOCU traded up $1.87 during midday trading on Monday, reaching $81.73. 5,039,194 shares of the stock traded hands, compared to its average volume of 2,646,872. The company's 50 day moving average is $75.53 and its 200 day moving average is $79.30. Docusign Inc. has a one year low of $54.31 and a one year high of $107.86. The stock has a market capitalization of $16.51 billion, a PE ratio of 61.45, a P/E/G ratio of 29.81 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.08. The company had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.Docusign's quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities analysts forecast that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its board has initiated a share repurchase program on Thursday, June 5th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 6.6% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its shares are undervalued.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Piper Sandler increased their price target on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday. Bank of America raised their price target on Docusign from $85.00 to $102.00 and gave the stock a "neutral" rating in a research note on Friday. Wells Fargo & Company raised their price target on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a report on Friday. JPMorgan Chase & Co. lifted their price objective on Docusign from $77.00 to $80.00 and gave the stock a "neutral" rating in a report on Friday. Finally, Argus reaffirmed a "hold" rating on shares of Docusign in a research report on Monday. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $94.14.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.